{"latest_checked": "2026-08-13T04:33:12.746470+00:00", "coverage_count": 5070, "recent_count": 6, "transaction_limit": 160, "filters": {"q": "", "ticker": "AGIO", "sector": "", "industry": "", "side": "", "start": "2026-06-30", "end": "2026-08-14"}, "summary": {"total": 6, "acquisition_count": 2, "disposal_count": 4, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 1064902.92, "disposal_value_label": "$1.1M", "net_value": -1064902.92, "net_value_label": "$-1.1M", "flow_tone": "negative", "largest_value_label": "$914.4K", "top_sector": "Healthcare", "window_label": "30 Jun 2026 to 14 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 6, "value": "1064902.9200", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.1M"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 100.0}, {"transaction_date": "2026-07-08", "acquisitions": 1, "disposals": 1, "total": 2, "bar_width": 66.7}, {"transaction_date": "2026-08-04", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 33.3}], "side_mix": {"acquisitions": 2, "disposals": 4, "acquisition_share": 33.3, "disposal_share": 66.7}}, "company_flows": [{"symbol": "AGIO", "name": "Agios Pharm", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-08-04", "acquisitions": 0, "disposals": 2, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1064902.92, "disposed_value_label": "$1.1M", "net_value": -1064902.92, "net_value_label": "$-1.1M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}], "company_overview": [{"symbol": "AGIO", "name": "Agios Pharm", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-08-04", "filings": 6, "acquisitions": 2, "disposals": 4, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1064902.92, "disposed_value_label": "$1.1M", "net_value": -1064902.92, "net_value_label": "$-1.1M", "acquisition_share": 33.3, "disposal_share": 66.7, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}], "transactions": [{"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "GHEUENS, SARAH", "executive_title": "Chief Medical Officer", "security_type": "Common stock", "side_code": "D", "side": "Disposal", "shares": 30000.0, "share_price": 30.48, "transaction_value": 914400.0, "transaction_value_label": "$914.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:24:29.837185+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}, {"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "BACKSTROM, JAY T.", "executive_title": "Director", "security_type": "Restricted stock units", "side_code": "D", "side": "Disposal", "shares": 1447.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-29T11:08:32.299168+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}, {"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "BACKSTROM, JAY T.", "executive_title": "Director", "security_type": "Common stock", "side_code": "A", "side": "Acquisition", "shares": 1447.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-07-29T11:08:32.302094+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}, {"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "GHEUENS, SARAH", "executive_title": "Chief Medical Officer", "security_type": "Common stock", "side_code": "A", "side": "Acquisition", "shares": 8375.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-07-22T11:04:39.943782+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}, {"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "GHEUENS, SARAH", "executive_title": "Chief Medical Officer", "security_type": "Restricted stock units", "side_code": "D", "side": "Disposal", "shares": 8375.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-22T11:04:39.945995+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}, {"symbol": "AGIO", "name": "Agios Pharm", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "GHEUENS, SARAH", "executive_title": "Chief Medical Officer", "security_type": "Common stock", "side_code": "D", "side": "Disposal", "shares": 4007.0, "share_price": 37.56, "transaction_value": 150502.92, "transaction_value_label": "$150.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-22T11:04:39.941713+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/agio/", "research_links": {"chart": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/", "report": "/terminal/cbdef60c-5d61-466e-a614-1b21fff2df99/report/", "factor": "/factors/ticker/cbdef60c-5d61-466e-a614-1b21fff2df99/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}